Results 191 to 200 of about 4,245 (206)

Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET

Radiotherapy and Oncology, 2012
Jolanta Kunikowska, Leszek Krolicki, Renata Mikołajczak   +2 more
exaly  

<p>Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights</p>

OncoTargets and Therapy, 2020
Jason S Starr, Mohamad Bassam Sonbol, Timothy J Hobday   +2 more
exaly  

Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy

Pharmaceuticals, 2019
Ute Hennrich, Klaus Kôpka, Kôpka Klaus   +2 more
exaly  

Chronic Complications of Peptide Receptor Radionuclide Therapy (PRRT) – A Single Center Experience.

2010
M Fraenkel, D Barak, J Mueller-Brand, Y Krausz, B Glaser, A Salmon, DJ Gross   +6 more
openaire   +1 more source

Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): A case report

Journal of Critical Care, 2020
Jayesh Dhanani, David A Pattison, Matthew Burge   +2 more
exaly  

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial

European Journal of Nuclear Medicine and Molecular Imaging, 2018
François-Alexandre Buteau, Jean-Mathieu Beauregard, Beauregard Jean-Mathieu   +2 more
exaly  

Assessment of infusion protocols for lutathera administration in peptide receptor radionuclide therapy (PRRT)

Physica Medica
A. Varallo, S. Grasso, C. Mainardi, M. Buono, C. Oliviero, R. Pastore, R. Schiano, D. Manzi, U. Crimaldi, S. Clemente   +9 more
openaire   +1 more source

External Beam Radiotherapy in Combination with Peptide Receptor Radionuclide Therapy (PRRT) in Irresectable or Recurrent Meningioma

International Journal of Radiation Oncology*Biology*Physics, 2011
B. Polat, M.C. Kreissl, H. Haenscheid, R. Sweeney, C. Reiners, A. Buck, M. Flentje   +6 more
openaire   +1 more source

Peptide Receptor Radionuclide Therapy (PRRT)

openaire   +1 more source

Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors

Hematology/Oncology Clinics of North America, 2016
Dik J Kwekkeboom, Eric P Krenning
exaly